US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Obstetrics/Gynecology: market research reports

Find the information you need on obstetrics/gynecology industry. Our collection of research reports provides insights into gynecological therapy advances and market trends, analysis, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
RSS Feeds

Obstetrics/Gynecology market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide
4/1/2014 | published by: Renub Research
... over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular ...  |  read more...
$1,490.00
Menopausal Hot Flashes - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Female Sexual Dysfunction - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Female Sexual Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Ovarian Cancer Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of ovarian cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 240 drug targets that are included in this drug-pathway analyzing ...  |  read more...
$5,622.50
Ovarian Cancer Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... an important secondary indication for existing and pipeline drugs. There are today 242 companies plus partners developing 335 drugs targeting ovarian cancer in development. In addition, there are 8 suspended drugs and the accumulated number ...  |  read more...
$5,622.50
US Non-Invasive Prenatal Testing Market Outlook 2018
3/1/2014 | published by: RNCOS
... age 35 or even 40. This trend has been attributed to numerous factors such as recession and associated affordability issues, and women being more focused on their careers than before. However, increased age of the ...  |  read more...
$1,200.00
Women Infertility - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Women Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Epithelial Ovarian Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Vulvovaginal Candidiasis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Vulvovaginal Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Endometrial Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Cervical Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Cervical Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Fallopian Tube Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Fallopian Tube Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Obstetrics Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
Gynecology Partnering Terms and Agreements
2/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter gynecology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
$2,995.00
Emerging Indian NIPT Market
2/1/2014 | published by: RNCOS
... quickest growing segment. Players, who are actively establishing their base in the US, are also fanning out to the EU and APAC regions. Interestingly, despite catching up on the Chinese, Japanese and Australian markets, players ...  |  read more...
$800.00
Obstretics Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Obstretics Partnering 2009-2014 provides understanding and access to the obstretics partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
$995.00
Ovarian Cancer Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... of ovarian cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ovarian cancer technology. These deals tend to ...  |  read more...
$995.00
Gynecology Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
Cervical Cancer Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... of cervical cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cervical cancer technology. These deals tend to ...  |  read more...
$995.00
Infertility Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Infertility Partnering 2009-2014 provides understanding and access to the infertility partnering deals and agreements entered into by the worlds ...  |  read more...
$995.00
Menopause Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Menopause Partnering 2009-2014 provides understanding and access to the menopause partnering deals and agreements entered into by the worlds ...  |  read more...
$995.00
Obstetrics Partnering Terms & Agreements
2/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter obstetrics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
$1,995.00
Prenatal Screening Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... partnering deals Top prenatal screening deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Prenatal Screening Partnering 2009-2014 provides understanding and access to the prenatal screening partnering deals ...  |  read more...
$695.00
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients